sleep case #1
DESCRIPTION
Sleep case #1. Case. 64 yo male smoker with hyperlipidemia BMI 28 Prev diagnosis of OSA Referred for daytime sleepiness. Prev results. 12/2006 sleep study: AHI 15.8 5/2007 PAP titration – good response to CPAP 6cm, 54 mins of sleep including REM-supine seen - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Sleep case #1](https://reader035.vdocument.in/reader035/viewer/2022070408/568143e8550346895db06f40/html5/thumbnails/1.jpg)
Sleep case #1
![Page 2: Sleep case #1](https://reader035.vdocument.in/reader035/viewer/2022070408/568143e8550346895db06f40/html5/thumbnails/2.jpg)
Case
• 64 yo male smoker with hyperlipidemia• BMI 28• Prev diagnosis of OSA• Referred for daytime sleepiness
![Page 3: Sleep case #1](https://reader035.vdocument.in/reader035/viewer/2022070408/568143e8550346895db06f40/html5/thumbnails/3.jpg)
Prev results
• 12/2006 sleep study: AHI 15.8• 5/2007 PAP titration – good response to CPAP
6cm, 54 mins of sleep including REM-supine seen
• Did not get home CPAP at that time• Summer 2012: Another provider started him
on CPAP based on 2006/2007 study results and ordered PSG which was performed in 10/2012
![Page 4: Sleep case #1](https://reader035.vdocument.in/reader035/viewer/2022070408/568143e8550346895db06f40/html5/thumbnails/4.jpg)
Visit Jan 2013• Started on CPAP over the summer 2012• Using it nightly and has met compliance with 4.5h
ave use• Feels he is sleeping better• No improvement in daytime sleepiness (ESS 18/24)• Irregular schedule• Difficulty falling and staying asleep• Estimates he gets 3-6 hours sleep/night• Works as a school bus driver
![Page 5: Sleep case #1](https://reader035.vdocument.in/reader035/viewer/2022070408/568143e8550346895db06f40/html5/thumbnails/5.jpg)
Assessment? Next steps?
Any special considerations in this patient?
![Page 6: Sleep case #1](https://reader035.vdocument.in/reader035/viewer/2022070408/568143e8550346895db06f40/html5/thumbnails/6.jpg)
10/2012 sleep study
![Page 7: Sleep case #1](https://reader035.vdocument.in/reader035/viewer/2022070408/568143e8550346895db06f40/html5/thumbnails/7.jpg)
Sleep study results 10/2012• TIB 424 min TST 344 min WASO 67 min • Sleep efficiency 81%• Sleep latency 11 mins, REM latency 17.5 mins• Sleep stages: 4.1% N1, 70.5% N2, 0% N3, 25.4%
REM• Position: 65 min supine, 278 min on left• AHI 5.2 overall, supine 10.9, REM 16.5, supine REM
57• Sat >90% entire study
![Page 8: Sleep case #1](https://reader035.vdocument.in/reader035/viewer/2022070408/568143e8550346895db06f40/html5/thumbnails/8.jpg)
Impression?Next steps?
![Page 9: Sleep case #1](https://reader035.vdocument.in/reader035/viewer/2022070408/568143e8550346895db06f40/html5/thumbnails/9.jpg)
PSG on CPAP/MSLT performed
![Page 10: Sleep case #1](https://reader035.vdocument.in/reader035/viewer/2022070408/568143e8550346895db06f40/html5/thumbnails/10.jpg)
![Page 11: Sleep case #1](https://reader035.vdocument.in/reader035/viewer/2022070408/568143e8550346895db06f40/html5/thumbnails/11.jpg)
![Page 12: Sleep case #1](https://reader035.vdocument.in/reader035/viewer/2022070408/568143e8550346895db06f40/html5/thumbnails/12.jpg)
![Page 13: Sleep case #1](https://reader035.vdocument.in/reader035/viewer/2022070408/568143e8550346895db06f40/html5/thumbnails/13.jpg)
PSG/MSLT results• PSG: TST 382 mins, efficiency 83%, CPAP
titrated from 6cm to 8cm. AHI 0.• MSLT– Nap 1: SL 1 min, REM latency 11 min– Nap 2: SL 1 min, no REM periods– Nap 3, SL 1 min, no REM periods– Nap 4: SL 4 min, no REM periods– Nap 5: SL 1 min, REM latency 5 min
• Mean SL: 1.8 min, 2 SOREMs
![Page 14: Sleep case #1](https://reader035.vdocument.in/reader035/viewer/2022070408/568143e8550346895db06f40/html5/thumbnails/14.jpg)
Diagnosis? Treatment?
![Page 15: Sleep case #1](https://reader035.vdocument.in/reader035/viewer/2022070408/568143e8550346895db06f40/html5/thumbnails/15.jpg)
Narcolepsy• #2 cause of daytime sleepiness (#1 = OSA)• Onset typically teens and early 20’s, but can be after
age 40• NL with and without cataplexy• Pathology of NL + cataplexy (~70%): loss of neurons
that produce orexin (a.k.a. hypocretin) – Wake-promoting– Stabilize wake/sleep– Inhibit REM
• NL without cataplexy less well-understood– Possibly less extensive loss of orexin
![Page 16: Sleep case #1](https://reader035.vdocument.in/reader035/viewer/2022070408/568143e8550346895db06f40/html5/thumbnails/16.jpg)
Symptoms of narcolepsy
• EDS• Fragmented sleep• REM-related phenomena intrude into
wakefulness– (Cataplexy)– Hypnagogic hallucinations– Sleep paralysis
![Page 17: Sleep case #1](https://reader035.vdocument.in/reader035/viewer/2022070408/568143e8550346895db06f40/html5/thumbnails/17.jpg)
Multiple Sleep Latency Test
• PSG the night before• 5 opportunities to nap, every 2 hours– 20 minutes to fall asleep– If fall asleep, allow 15 minutes of sleep
• Data obtained:– Number of naps in which sleep is obtained– Mean sleep latency • If no sleep, 20 minutes for that nap
– Number of SOREMs
![Page 18: Sleep case #1](https://reader035.vdocument.in/reader035/viewer/2022070408/568143e8550346895db06f40/html5/thumbnails/18.jpg)
Diagnosis of Narcolepsy
• EDS + cataplexy• Narcolepsy without cataplexy – definitive
diagnosis– Mean SL < 8 mins– ≥ 2 SOREMs
![Page 19: Sleep case #1](https://reader035.vdocument.in/reader035/viewer/2022070408/568143e8550346895db06f40/html5/thumbnails/19.jpg)
Treatment of Narcolepsy• Wake-promoting agents– Modafinil/armodafinil (provigil/nuvigil)
• Likely increase dopa signaling
– Amphetamines• e.g Methylphenidate
• REM-suppressing drugs– Increase norepi and serotonin
• Venlafaxine• Fluoxetine• Tricyclics
– Sodium oxybate at bedtime (analog of GHB, GABA analog)